32 results
SC TO-C
EX-2.1
INVA
Innoviva, Inc.
11 Jul 22
Information about tender offer
3:46pm
the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders … ; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties
SC TO-C
EX-10.1
INVA
Innoviva, Inc.
11 Jul 22
Information about tender offer
3:46pm
, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter … genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties hereto agree that any rule of construction to the effect
8-K
EX-2.1
INVA
Innoviva, Inc.
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders … ; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties
8-K
EX-10.1
oo2gjelp9j4gkqt81jnh
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
0ptki6vlilan6 4u55
11 Jul 22
Business combination disclosure
7:38am
SC TO-C
EX-2.1
awuwopj05cr
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
m1ifoms37q1ckhk 9n
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-10.2
wz36ry8nnlgsfd71jh
14 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.5
jum2k3
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
0qvya49ac4xji06l
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
falvm7hqu wfntxmgn
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.3
8tbe5o0f eyh
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-4.4
v32q 6g5629
25 Jan 13
Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes
12:00am
S-3ASR
EX-4.4
091ccwuj2 gg
16 Jan 13
Automatic shelf registration
12:00am
8-K
EX-99.11
q0e4tf0yn5 plb97hg
4 Sep 12
Other Events
12:00am
8-K
EX-99.6
0klbmb0gcoa tq
4 Sep 12
Other Events
12:00am
8-K
EX-99.13
zl9y7erymg
4 Sep 12
Other Events
12:00am